WHO panel proposed treaty requires all governments to share cost India supports a proposed legally binding global instrument that requires all governments to share the cost of research and development (R&D). The treaty, recommended by a World Health Organisation panel, will boost access to countries least able to pay for medical innovations but need it most. This would also delink profits from medical discoveries. The “Consultative Expert Working Group on Research and...
More »SEARCH RESULT
Total Matching Records found : 383
Soon, breath test to tell Tuberculosis in just 6 minutes-Malathy Iyer
A breath test to detect the deadly Tuberculosis (TB) bacteria in six minutes flat has been developed in the US, with help from experts in Mumbai. Doctors from Hinduja Hospital in Mahim and the state-run JJ Hospital in Byculla have helped validate the prototype for the point-of-breath test, according to an article published in medical journal 'Tuberculosis' recently. The test could emerge as the quickest way to screen a patient for...
More »How PH Kurien took on global patents system to make very costly drug affordable for poor-Arvind Panagariya
It is said that only God and a few good men and women run India. One such man is P H Kurien. For readers unfamiliar with his name, Kurien was India's Controller General of Patents, Designs & Trade Marks until March 12, 2012. On March 9, 2012, just three days before he left office, he issued the first-ever compulsory licence in India for the manufacture of a drug still under patent....
More »On WHO agenda: a global vaccine action plan-Sonal Matharu
Health activists say new policy may not address the weaknesses in ongoing routine immunisation programmes and would flood poor countries with new vaccines When the global health leaders meet in Geneva from May 21 to 26 for the World Health Organization's 65th General Assembly, introducing new vaccines in the low- and middle-income countries would be high on their agenda. A “global draft vaccine action plan”, available on WHO's website, details the implementation...
More »Indians popping more antibiotics than ever: Study-Kounteya Sinha
There has been a six-fold increase in the number of antibiotics being popped by Indians. This includes the retail sale of Carbapenems -- powerful class IV antibiotics, typically used as a "last resort" to treat serious infections caused by multi-drug resistant, gram-negative pathogens. Research by the Centre for Disease Dynamics, Economics and Policy, Washington DC, has found that retail sale of carbapenems increased six times -- from 0.21 units per million...
More »
